Geron reported $64.28M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Amgen USD 20.48B 2.53B Jun/2025
Bio Techne USD 175.85M 6.64M Jun/2025
Cassava Sciences USD 47.33M 35.58M Jun/2025
Cytokinetics USD 131.06M 28.66M Jun/2025
Exelixis USD 336.11M 62.99M Jul/2025
Genmab DKK 629M 127M Jun/2025
Geron USD 64.28M 1.25M Jun/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
Incyte USD 1.28B 608.18M Jun/2025
MacroGenics USD 39M 16.53M Jun/2025
Novartis USD 31.71B 95M Jun/2025